Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine p ...
After finishing Episode 6, feel free to use our Episode 7 guide. If it is not enough for you, we have also prepared a guide with all chapters, choices and some useful tips. Have fun. If you want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results